Literature DB >> 31954751

Concerns about the use of metformin as a first-line agent to slow the progression of chronic kidney disease in diabetes.

Milton Packer1.   

Abstract

Entities:  

Year:  2020        PMID： 31954751     DOI： 10.1016/j.diabres.2020.108024

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN： 0168-8227            Impact factor:   5.602


× No keyword cloud information.
  1 in total

1.  Are the benefits of SGLT2 inhibitors in heart failure and a reduced ejection fraction influenced by background therapy? Expectations and realities of a new standard of care.

Authors:  Milton Packer
Journal:  Eur Heart J       Date:  2020-07-01       Impact factor: 29.983
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.